MPM BioVentures - Representative Investments

Accelerator Corporation

Life enhancing biotechnology

Acorda Therapeutics, Inc.

Spinal cord injury, multiple sclerosis

Affymax, Inc.

Drug discovery - Glaxo spinout

Alinea Pharmaceuticals, Inc.

Diabetes and related metabolic disorders

Amphora Discovery Corporation

Drug discovery - Caliper spinout

Arriva Pharmaceuticals, Inc.

Enzyme inhibitor replacement & therapy

ARYx Therapeutics, Inc.

Retro-metabolic drug design

Aveo Pharmaceuticals, Inc.

Cancer drug discovery and development

Barrier Therapeutics, Inc.

Development of novel dermatological therapeutics

BioVitrum, AB

Biopharmaceuticals for metabolic & blood disorders

BioXell SpA

Drug discovery - Roche spinout

Cellerant Therapeutics Inc.

Hematopoietic (blood-forming) stem cell-based therapies 

Ceregene, Inc.

Treatment of neurodegenerative disorders using gene therapy

Cerimon Pharmaceuticals, Inc.

Autoimmune disease, inflammation and pain therapeutics

CGI Pharmaceuticals, Inc.

Selective kinase inhibitors

Chiasma

Developer of innovative platform technologies that enable oral delivery of large molecules and other impermeable drugs

CoTherix, Inc.

Therapeutics for life threatening diseases

Critical Therapeutics, Inc.

Pharmaceuticals for critical care